Wyeth Biotech is first New England biopharmaceutical plant
to enter OSHA’s Voluntary Protection Programs, according to an agency release
Friday. The Andover, Mass., company was officially accepted into the program in
a ceremony held Friday in Andover.
Wyeth's Andover research, development and manufacturing
campus and its Wilmington administrative offices have been approved for three
years of participation in the VPP at the "star," or highest
achievement, level, according to the OSHA release.
The acceptance followed an OSHA team's week-long onsite
review, according to the agency. The team found that the facilities' safety and
health programs were consistent with the high quality expected of VPP
participants, and their injury and illness rates were well below the industry
average.
Among the areas of excellence identified during OSHA's
review was extensive use of process hazard analysis to identify and address
risks associated with new or existing processes and equipment.
Pharmaceutical Plant Enters VPPP (6/9)